Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immunotherapy in glioblastoma treatment: Current state and future prospects
Samuel Luca Rocha Pinheiro, Fabian Fellipe Bueno Lemos, Hanna Santos Marques, et al.
World Journal of Clinical Oncology (2023) Vol. 14, Iss. 4, pp. 138-159
Open Access | Times Cited: 51

Showing 1-25 of 51 citing articles:

Glioblastoma Therapy: Past, Present and Future
Elena Obrador, Paz Moreno-Murciano, María Oriol‐Caballo, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2529-2529
Open Access | Times Cited: 61
Revolutionizing Glioblastoma Treatment: A Comprehensive Overview of Modern Therapeutic Approaches
Karol Sadowski, Adrianna Jażdżewska, Jan Kozłowski, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 5774-5774
Open Access | Times Cited: 16
Lipid Nanocarriers as Precision Delivery Systems for Brain Tumors
Roshan Keshari, Mahima Dewani, Navneet Kaur, et al.
Bioconjugate Chemistry (2025)
Closed Access | Times Cited: 2
Hypoxia within the glioblastoma tumor microenvironment: a master saboteur of novel treatments
Lisa Feldman
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 11
Role of gut microbiota in regulating immune checkpoint inhibitor therapy for glioblastoma
Hao Zhang, Ying Hong, Tingting Wu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 10
Integrating Multisector Molecular Characterization into Personalized Peptide Vaccine Design for Patients with Newly Diagnosed Glioblastoma
Tanner M. Johanns, Elizabeth A.R. Garfinkle, Katherine E. Miller, et al.
Clinical Cancer Research (2024) Vol. 30, Iss. 13, pp. 2729-2742
Open Access | Times Cited: 8
Molecular mechanisms of tumour development in glioblastoma: an emerging role for the circadian clock
Nina Nelson, Angela Relógio
npj Precision Oncology (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 6
Clinical research framework proposal for ketogenic metabolic therapy in glioblastoma
Tomás Duraj, Miriam Kalamian, Giulio Zuccoli, et al.
BMC Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 6
Gender Differences and miRNAs Expression in Cancer: Implications on Prognosis and Susceptibility
Santino Caserta, Sebastiano Gangemi, Giuseppe Murdaca, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11544-11544
Open Access | Times Cited: 14
The immunological landscape of peripheral blood in glioblastoma patients and immunological consequences of age and dexamethasone treatment
Sophie A. Dusoswa, Jan Verhoeff, Saskia D. van Asten, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
Glioblastoma multiforme - a rare type of cancer: A narrative review
Gaurvi Bijalwan, Abhishek Kumar Shrivastav, Sarita Mallik, et al.
Cancer Research Statistics and Treatment (2024) Vol. 7, Iss. 3, pp. 340-351
Open Access | Times Cited: 4
Immune Resistance in Glioblastoma: Understanding the Barriers to ICI and CAR-T Cell Therapy
Thomas Eckert, M. S. Zobaer, Jessie Boulos, et al.
Cancers (2025) Vol. 17, Iss. 3, pp. 462-462
Open Access
Why Do Glioblastoma Treatments Fail?
Alen Rončević, Nenad Koruga, Anamarija Soldo Koruga, et al.
Future Pharmacology (2025) Vol. 5, Iss. 1, pp. 7-7
Open Access
Immunity/metabolism dual-regulation via an acidity-triggered bioorthogonal assembly nanoplatform enhances glioblastoma immunotherapy by targeting CXCL12/CXCR4 and adenosine-A2AR pathways
Ruili Wei, Kunfeng Xie, Tao Li, et al.
Biomaterials (2025) Vol. 319, pp. 123216-123216
Closed Access
γδ T cells as a potential therapeutic agent for glioblastoma
In Kang, Yumin Kim, Heung Kyu Lee
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 9
Signaling Pathways of AXL Receptor Tyrosine Kinase Contribute to the Pathogenetic Mechanisms of Glioblastoma
Alberto Repici, Alessio Ardizzone, Fabiola De Luca, et al.
Cells (2024) Vol. 13, Iss. 4, pp. 361-361
Open Access | Times Cited: 3
Modulation of the Immune Environment in Glioblastoma by the Gut Microbiota
George B. H. Green, Alexis N. Cox-Holmes, Anna Claire E. Potier, et al.
Biomedicines (2024) Vol. 12, Iss. 11, pp. 2429-2429
Open Access | Times Cited: 3
Navigating the Immune Challenge in Glioblastoma: Exploring Immunotherapeutic Avenues for Overcoming Immune Suppression
Prateek Jain, Shambhavi Vashist, Binay K Panjiyar
Cureus (2023)
Open Access | Times Cited: 7
Pan-cancer analyses identify MIR210HG overexpression, epigenetic regulation and oncogenic role in human tumors and its interaction with the tumor microenvironment
Garima Yadav, Ritu Kulshreshtha
Life Sciences (2024) Vol. 339, pp. 122438-122438
Closed Access | Times Cited: 2
Natural Food Components as Biocompatible Carriers: A Novel Approach to Glioblastoma Drug Delivery
Arunraj Tharamelveliyil Rajendran, Anoop Narayanan Vadakkepushpakath
Foods (2024) Vol. 13, Iss. 17, pp. 2812-2812
Open Access | Times Cited: 2
-New frontiers in domain-inspired radiomics and radiogenomics: increasing role of molecular diagnostics in CNS tumor classification and grading following WHO CNS-5 updates
Gagandeep Singh, Annie Singh, Joseph Bae, et al.
Cancer Imaging (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Status Quo in the Liposome-Based Therapeutic Strategies Against Glioblastoma: “Targeting the Tumor and Tumor Microenvironment”
Mohd Haseeb, Imran Khan, Zeynep Kartal, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 20, pp. 11271-11271
Open Access | Times Cited: 2
Immunomodulatory R848-Loaded Anti-PD-L1-Conjugated Reduced Graphene Oxide Quantum Dots for Photothermal Immunotherapy of Glioblastoma
Yu‐Jen Lu, Reesha Kakkadavath Vayalakkara, Banendu Sunder Dash, et al.
Pharmaceutics (2024) Vol. 16, Iss. 8, pp. 1064-1064
Open Access | Times Cited: 1
Immunological challenges and opportunities in glioblastoma multiforme: A comprehensive view from immune system lens
Jayant Singh Bhardwaj, Shivangi Paliwal, Gautam Singhvi, et al.
Life Sciences (2024) Vol. 357, pp. 123089-123089
Closed Access | Times Cited: 1
Recent Developments in Glioblastoma‐On‐A‐Chip for Advanced Drug Screening Applications
Surjendu Maity, Tamanna Bhuyan, Christopher M. Jewell, et al.
Small (2024)
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top